Royalty Pharma plc (RPRX) Stock buybacks 2018–2025
Royalty Pharma plc (RPRX) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$1.2BFY2025 · since FY2018: $0 → $1.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.2B | +434.5% |
| FY2024 | $229.7M | -24.6% |
| FY2023 | $304.8M | — |
| FY2022 | $0 | — |
| FY2021 | $0 | — |
| FY2020 | $0 | -100.0% |
| FY2019 | $4.3M | — |
| FY2018 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RPRX financial trends
RPRX RevenueRPRX Net incomeRPRX Net marginRPRX Gross profitRPRX Gross marginRPRX Operating incomeRPRX Operating marginRPRX Operating cash flowRPRX Free cash flowRPRX Capital expendituresRPRX Return on equityRPRX Dividends paidRPRX Total assetsRPRX Total liabilitiesRPRX Shareholders’ equityRPRX overview →